Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.
复制标题
DOI:
10.1073/pnas.86.22.9011
复制
发表时间:
1989-11
影响因子:
11.1
通讯作者:
J. Wolff;Lisa J. Fishers;Li Xu;Hyder A. JINNAHt;Philip J. LANGLAISt;P. M. Iuvoneii;K. O’Malley;M. B. Rosenberg;Shun SHIMOHAMAt;Théodore;Friedmann;Fred H. GAGEttt
中科院分区:
文献类型:
--
作者:
J. Wolff;Lisa J. Fishers;Li Xu;Hyder A. JINNAHt;Philip J. LANGLAISt;P. M. Iuvoneii;K. O’Malley;M. B. Rosenberg;Shun SHIMOHAMAt;Théodore;Friedmann;Fred H. GAGEttt
Rat fibroblasts were infected with a retroviral vector containing the cDNA for rat tyrosine hydroxylase [TH; tyrosine 3-monooxygenase; L-tyrosine, tetrahydropteridine:oxygen oxidoreductase (3-hydroxylating), EC 1.14.16.2]. A TH-positive clone was identified by biochemical assay and immunohistochemical staining. When supplemented in vitro with pterin cofactors required for TH activity, these cells produced L-dopa and released it into the cell culture medium. Uninfected control cells and fibroblasts infected with the TH vector were grafted separately to the caudate of rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. Only grafts containing TH-expressing fibroblasts were found to reduce rotational asymmetry. These results have general implications for the application of gene therapy to human neurological disease and specific implications for Parkinson disease.